ArticleBMC gastroenterology2023

Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis.

Daniel J Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.